Descending serotonergic, peptidergic and cholinergic pathways from the raphe nuclei: a multiple transmitter complex

Topographic principles in the spinal projections of serotonergic and non-serotonergic brainstem neurons in the rat

The spinal projections from the raphe-associated brainstem areas containing serotonergic neurons were studied with aldehyde-induced fluorescence in combination with the retrograde fluorescent tracer True Blue in the rat. This technique makes it possible to determine simultaneously the projections of individual neurons and to detect whether serotonin is present in the same neurons. After tracer injections into the spinal cord retrogradely labeled serotonergic and non-serotonergic neurons were found in the medullary raphe nuclei and adjacent regions and to a lesser extent in association with the dorsal and median raphe nuclei in the mesencephalon. Large True Blue injections that covered one side of the spinal cord at mid-cervical level labeled about 60% of the ipsilaterally situated serotonergic neurons in the medullary raphe regions while the corresponding figure contralaterally was about 25%. On both sides a larger number of labeled non-serotonergic neurons were found; these were sometimes located dorsal to, but often intermingled with, the serotonergic cells. While the serotonergic projection from the mesencephalon could not be labeled from injections below cervical levels, the labeling in more caudal brainstem regions exhibited only minor variations depending on the rostrocaudal level of the spinal segment injected. Furthermore, quantitative data from injections at different levels indicate that the majority of the spinal-projecting neurons traverse most of the length of the cord. Summarizing the results obtained from small injections restricted to subregions of the cord we feel that it is possible to distinguish three fairly distinct pathways for spinal projections from the medullary raphe and adjacent regions: The dorsal pathway originates mainly from cells in the caudal pons and rostral medulla oblongata (rostral part of nucleus raphe magnus, nucleus raphe magnus proper, nucleus reticularis gigantocellularis pars alpha and nucleus paragigantocellularis). This pathway, which contains a large non-serotonergic component, descends through the dorsal part of the lateral funiculus and terminates mainly in the dorsal horn at all spinal cord levels. The intermediate pathway is largely serotonergic with its cell bodies located within the arcuate cell group (situated just ventral and lateral to the pyramids very close to the ventral surface of the brainstem) and in the nucleus raphe obscurus and pallidus and terminates in the intermediate grey at thoracolumbar and upper sacral levels.(ABSTRACT TRUNCATED AT 400 WORDS)

A comparison of the effects of serotonin, substance P and thyrotropin-releasing hormone on excitability of rat spinal motoneurons in vivo

Lumbar spinal motoneurons of urethane-anesthetized rats were driven at stable low firing rates by automatically cycled iontophoretic applications of glutamate or aspartate. The effects of iontophoretically applied serotonin, substance P or thyrotropin-releasing hormone (TRH) on glutamate or aspartate-evoked activity were then tested. All 3 substances were found to enhance both glutamate- and aspartate-induced excitation of the motoneurons. This enhancement of excitability was usually preceded by a brief period of inhibition at current onset. Although the effects of serotonin and substance P were qualitatively remarkably similar, TRH differed in that TRH occasionally inhibited motoneuron excitability without subsequent facilitation, and tachyphylaxis developed for the facilitatory effects of TRH. After TRH desensitization, serotonin could still enhance spinal motoneuron excitability.

The ultrastructure and synaptic connections of the spinal terminations from single, physiologically characterized axons descending in the dorsolateral funiculus from the midline, pontomedullary region

Single axons descending in the spinal, dorsolateral funiculus which were directly activated by stimulating in or near nucleus raphe magnus (nRM) in the rostral medulla were iontophoretically injected with horseradish peroxidase (HRP). Labeled axons and terminal arborizations in the spinal cord were demonstrated by diaminobenzidine histochemistry following fixation. Sections were processed for electron microscopy and embedded between coverslips. Following examination with the light microscope, selected boutons were sectioned in ultrathin series and examined with the electron microscope. Two arborization patterns were observed with the light microscope. One terminated dorsally in laminae I, II, V, and X, while the other terminated ventrally in laminae V, VII, and X. At the ultrastructural level, boutons predominantly contacted dendrites and occasionally contacted cell somas. Ventrally projecting axons had boutons characterizable as Gray's type I. Some dorsally projecting axons also had Gray's type I boutons, while other axons had Gray's type II boutons. Thus, these descending axons may be heterogeneous in function. No differences in physiological characteristics were found between axons with Gray's type I boutons versus axons with Gray's type II boutons.

Serotonin and co-localized peptides: effects on spinal motoneuron excitability

Iontophoretically applied serotonin (5HT), substance P (SP), thyrotropin releasing hormone (TRH) and proctolin all enhanced spinal motoneuron activity evoked by glutamate in urethane-anesthetized rats. 5HT and SP produced more consistent facilitation of excitability both within and between motoneurons than did TRH and proctolin which failed to facilitate several motoneurons. It is concluded that 5TH, SP, TRH and proctolin, which appear to co-exist in various combinations in ventral horn terminals near spinal motoneurons, have complimentary effects on motoneuron excitability.

Bulbospinal substance P and sympathetic regulation of the cardiovascular system: a review

The neurotransmitter role of substance P in mediating sympathoexcitatory effects in the spinal cord and cardiovascular effects elicited from the ventral medulla is presented. SP neurons located in the ventral medulla project to the intermediolateral cell column (IML) of the thoracic spinal cord. Intrathecal administration of a SP analog excites sympathetic outflow to the cardiovascular system. Likewise, activation of the ventral medulla results in sympathetically mediated increases in blood pressure and heart rate which are blocked with SP antagonists. The IML contained a high density of SP binding sites through which the peptide likely exerts its sympathoexcitatory influence on the cardiovascular system.

Retrograde tracing of neural pathways with a protein-gold complex. I. Light microscopic detection after silver intensification

In this study I have used a tracer complex made of wheat germ agglutinin horseradish peroxidase conjugate (WGA*HRP) coupled to colloidal gold for retrograde tracing of neuronal pathways at the light microscopic level. Visualization of the gold was achieved by silver precipitation (the gold silver intensification method) with gold particles acting as specific cores of nucleation. The presence of horseradish peroxidase in the protein conjugate allowed this method to be compared with classical histochemistry using tetramethylbenzidine as a chromogen. The gold silver intensification method proved to be reliable, specific and sensitive. It has been demonstrated to be useful with fixatives containing a high percentage of paraformaldehyde and compatible with histochemical procedures to show projections of transmitter specific pathways.

Chemical anatomy of the brain

The development of sensitive histochemical-neuroanatomical techniques has made it possible to analyze the content of specific compounds in single nerve cells and their processes. In consequence, it has been possible to construct detailed maps of the distribution of various types of neurons on the basis of their transmitter substance. There are now many examples of neurons containing both a classical transmitter and a peptide. In some instances the peptides seem to support the action of the classical transmitters. This interaction may have applications in the prevention and treatment of nervous disease states.